AWK vs PMCB
American Water Works (AWK) versus PharmaCyte Biotech Inc (PMCB) — a side-by-side from cached financials, not a winner call.
American Water Works (AWK) is a utilities - regulated water company listed on US.
PharmaCyte Biotech Inc (PMCB) is a biotechnology company listed on NASDAQ.
Latest reported AWK revenue for 2024-12-31 was $4.65B. Net income was $239.0M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
Latest reported PMCB revenue for 2025-04-30 was $0. Net income was $30.7M. PMCB currently screens at market cap $8.6M.
AWK currently screens at market cap $24.31B and trailing P/E 22.1. PMCB currently screens at market cap $8.6M.
Not investment advice. Open the AWK and PMCB stock pages for the full models.
Not investment advice.